These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35850699)

  • 1. The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.
    Ficenec SC; Grant DS; Sumah I; Alhasan F; Yillah MS; Brima J; Konuwa E; Gbakie MA; Kamara FK; Bond NG; Engel EJ; Shaffer JG; Fischer WA; Wohl DA; Emmett SD; Schieffelin JS
    BMC Infect Dis; 2022 Jul; 22(1):624. PubMed ID: 35850699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone.
    Bond NG; Grant DS; Himmelfarb ST; Engel EJ; Al-Hasan F; Gbakie M; Kamara F; Kanneh L; Mustapha I; Okoli A; Fischer W; Wohl D; Garry RF; Samuels R; Shaffer JG; Schieffelin JS
    Clin Infect Dis; 2021 Sep; 73(6):1046-1054. PubMed ID: 33822010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Ebola sequelae among Ebola child survivors in Sierra Leone.
    Amuzu C; James PB; Bah AJ; Bayoh AVS; Singer SR
    BMC Pediatr; 2021 Oct; 21(1):482. PubMed ID: 34717580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study.
    Mattia JG; Vandy MJ; Chang JC; Platt DE; Dierberg K; Bausch DG; Brooks T; Conteh S; Crozier I; Fowler RA; Kamara AP; Kang C; Mahadevan S; Mansaray Y; Marcell L; McKay G; O'Dempsey T; Parris V; Pinto R; Rangel A; Salam AP; Shantha J; Wolfman V; Yeh S; Chan AK; Mishra S
    Lancet Infect Dis; 2016 Mar; 16(3):331-8. PubMed ID: 26725449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) study: Lessons learned for vision health systems strengthening in Sierra Leone.
    Shantha JG; Crozier I; Kraft CS; Grant DG; Goba A; Hayek BR; Hartley C; Barnes KG; Uyeki TM; Schieffelin J; Garry RF; Bausch DG; Farmer PE; Mattia JG; Vandy MJ; Yeh S;
    PLoS One; 2021; 16(7):e0252905. PubMed ID: 34242218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone.
    Tiffany A; Vetter P; Mattia J; Dayer JA; Bartsch M; Kasztura M; Sterk E; Tijerino AM; Kaiser L; Ciglenecki I
    Clin Infect Dis; 2016 Jun; 62(11):1360-1366. PubMed ID: 27001797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort.
    Bond NG; Shore KR; Engel EJ; Coonan EE; Al-Hasan F; Gbakie MA; Kamara FK; Kanneh L; Momoh M; Kanneh IM; Sandi JD; Elliott D; Ficenec SC; Smira AR; Fischer WA; Wohl DA; Robinson JE; Shaffer JG; Garry RF; Samuels RJ; Grant DS; Schieffelin JS
    J Infect Dis; 2024 Oct; 230(4):e929-e937. PubMed ID: 38801652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conducting mixed-methods research with Ebola survivors in a complex setting in Sierra Leone.
    Alva S; Davis N; Stan L; Pivato I; Sanderson J
    BMC Public Health; 2020 Sep; 20(1):1346. PubMed ID: 32883281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak.
    Arranz J; Lundeby KM; Hassan S; Zabala Fuentes LM; San José Garcés P; Haaskjold YL; Bolkan HA; Krogh KØ; Jongopi J; Mellesmo S; Jøsendal O; Øpstad Å; Svensen E; Kamara AS; Roberts DP; Stamper PD; Austin P; Moosa AJ; Marke D; Berg Å; Blomberg B; Riera M
    BMC Infect Dis; 2016 Jun; 16():308. PubMed ID: 27334891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear, distress, and perceived risk shape stigma toward Ebola survivors: a prospective longitudinal study.
    Antonaccio CM; Pham P; Vinck P; Collet K; Brennan RT; Betancourt TS
    BMC Public Health; 2021 Nov; 21(1):2066. PubMed ID: 34763704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Retinal Lesion in Ebola Survivors, Sierra Leone, 2016.
    Steptoe PJ; Scott JT; Baxter JM; Parkes CK; Dwivedi R; Czanner G; Vandy MJ; Momorie F; Fornah AD; Komba P; Richards J; Sahr F; Beare NAV; Semple MG
    Emerg Infect Dis; 2017 Jul; 23(7):1102-1109. PubMed ID: 28628441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stigmatization of Ebola virus disease survivors in 2022: A cross-sectional study of survivors in Sierra Leone.
    Schindell BG; Kangbai JB; Shaw SY; Kindrachuk J
    J Infect Public Health; 2024 Jan; 17(1):35-43. PubMed ID: 37992432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life among Ebola survivors in Sierra Leone: the role of socio-demographic, health-related and psycho-social factors.
    James PB; Wardle J; Gyasi RM; Steel A; Adams J; Kabba JA; Bah AJ; Lahai M; Conteh EB
    Health Qual Life Outcomes; 2022 Jan; 20(1):10. PubMed ID: 35033102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of mental health among Ebola virus disease survivors through a cross-sectional study in Sierra Leone.
    Schindell BG; Fredborg B; Kowalec K; Shaw S; Kangbai JB; Kindrachuk J
    BMJ Glob Health; 2024 May; 9(5):. PubMed ID: 38782464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disability Among Ebola Survivors and Their Close Contacts in Sierra Leone: A Retrospective Case-Controlled Cohort Study.
    Jagadesh S; Sevalie S; Fatoma R; Sesay F; Sahr F; Faragher B; Semple MG; Fletcher TE; Weigel R; Scott JT
    Clin Infect Dis; 2018 Jan; 66(1):131-133. PubMed ID: 29020205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of Ebola-related stigma and its association with informal healthcare utilisation among Ebola survivors in Sierra Leone: a cross-sectional study.
    James PB; Wardle J; Steel A; Adams J
    BMC Public Health; 2020 Feb; 20(1):182. PubMed ID: 32020858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Ebola virus disease surveillance system in Tonkolili District, Sierra Leone.
    Ilesanmi OS; Fawole O; Nguku P; Oladimeji A; Nwenyi O
    Pan Afr Med J; 2019; 32(Suppl 1):2. PubMed ID: 30984324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV prevalence in suspected Ebola cases during the 2014-2016 Ebola epidemic in Sierra Leone.
    Liu WJ; Hu HY; Su QD; Zhang Z; Liu Y; Sun YL; Yang XD; Sun DP; Cai SJ; Yang XX; Kamara I; Kamara A; Lebby M; Kargbo B; Ongpin P; Dong XP; Shu YL; Xu WB; Wu GZ; Gboun M; Gao GF
    Infect Dis Poverty; 2019 Mar; 8(1):15. PubMed ID: 30827277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study.
    Waxman M; Aluisio AR; Rege S; Levine AC
    Lancet Infect Dis; 2017 Jun; 17(6):654-660. PubMed ID: 28258817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016.
    Abad N; Malik T; Ariyarajah A; Ongpin P; Hogben M; McDonald SLR; Marrinan J; Massaquoi T; Thorson A; Ervin E; Bernstein K; Ross C; Liu WJ; Kroeger K; Durski KN; Broutet N; Knust B; Deen GF;
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005827. PubMed ID: 28892490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.